Viewing Study NCT05355350

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2026-01-27 @ 5:38 PM
Study NCT ID: NCT05355350
Status: WITHDRAWN
Last Update Posted: 2025-07-24
First Post: 2022-04-04
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections
Sponsor: Rambam Health Care Campus
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Beta Lactam Resistant Bacterial Infection View
None Enterobacteriaceae Infections View
None Bacteremia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bacteremia View
None enterobacteriaceae View
None extended spectrum beta-lactamase View
None meropenem View
None piperacillin tazobactam View